Target Name: RNA5SP63
NCBI ID: G100873298
Other Name(s): RN5S63 | RNA, 5S ribosomal pseudogene 63

RNA5SP63: A Potential Drug Target and Biomarker

RNA5SP63 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of cancer. RNA5SP63 has been shown to play a role in the regulation of cell growth, apoptosis, and angiogenesis.

The Drug Target Potential

RNA5SP63 has been identified as a potential drug target due to its involvement in the regulation of cell cycle progression. It has been shown to inhibit the G1 phase of the cell cycle, which is crucial for cell growth and division. This inhibition leads to the arrest of cell growth and the start of the G2 phase, which is a critical phase for cell preparation for division.

RNA5SP63 has also been shown to play a role in the regulation of apoptosis. Apoptosis is a natural process that helps the body eliminate damaged or dysfunctional cells. However, in cancer cells, apoptosis is often inhibited, leading to the survival and proliferation of these cells. RNA5SP63 has been shown to regulate the execution of apoptotic programmed cell death, which is a critical step in the regulation of cell death.

In addition to its role in cell cycle progression and apoptosis, RNA5SP63 has also been shown to be involved in the regulation of angiogenesis. Angiogenesis is the process by which new blood vessels are formed in the body, and it is a critical process for the development of many diseases, including cancer. RNA5SP63 has been shown to regulate the formation of blood vessels in the brain and has been shown to play a role in the development of neurodegenerative diseases.

The Biomarker Potential

RNA5SP63 has also been identified as a potential biomarker for cancer. Its involvement in the regulation of cell cycle progression, apoptosis, and angiogenesis makes it an attractive target for cancer diagnostics and therapies. RNA5SP63 has been shown to be expressed in a variety of cancer types, including breast, lung, and ovarian cancer. It has also been shown to be involved in the regulation of cancer cell survival and has been shown to be a potential therapeutic target for cancer treatment.

Conclusion

RNA5SP63 is a non-coding RNA molecule that has been shown to play a role in the regulation of cell cycle progression, apoptosis, and angiogenesis. Its potential as a drug target and biomarker makes it an attractive target for cancer research and treatment. Further studies are needed to fully understand the role of RNA5SP63 in cancer and to develop effective therapies based on its targeting.

Protein Name: RNA, 5S Ribosomal Pseudogene 63

More Common Targets

RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220